Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The initial stream of a urine void.

Project description

Diagnostic and prognostic tool to replace cervical samples in the clinic

For many women, the prospect of having cervical samples taken to screen for cancer is distressing and unpleasant. Some even abstain from regular screening protocols, leaving those at-risk without timely diagnosis and treatment. Meanwhile, non-invasive self-sampling methodologies are gaining wider acceptance. A notable example is the first-void urine (FVU) sample to screen for Human Papillomavirus in women. The ERC-funded FVU project has been developing infection and vaccine models to demonstrate that FVU is an ideal liquid genital tract biopsy to monitor immune response. Ultimately, it aims to illustrate that the FVU sample could be a valuable tool for a range of diagnostic, screening, monitoring and prognostic applications in the field of sexually transmitted infections.

Objective

The ability to easily obtain appropriate and reliable biological samples is critical to advancing life sciences and public/personal health. Having a sample that is non-invasive and can be self-collected at home has major acceptance and implementation advantages. Our team has already demonstrated that first-void urine (FVU) samples can replace clinician-collected cervical samples in Human Papillomavirus (HPV) based cervical cancer screening. Using the initial or first-void urine stream is crucial here. Indeed, the outer layers of the epithelium of the genital tract exfoliate and together with the genital mucus form the utero-cervico-vaginal secretions. This discharge accumulates between the labia minora, around the urethral opening, and is washed away with the FVU upon initiation of urination. The URISAMP project is making good progress to demonstrate that, using HPV infection and vaccination as a model, FVU is indeed an ideal genital tract liquid biopsy to monitor both disease and immune response of women at the site of infection. Importantly, diagnostic, screening, and monitoring applications via FVU samples are growing.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

UNIVERSITEIT ANTWERPEN
Net EU contribution
€ 150 000,00
Address
PRINSSTRAAT 13
2000 Antwerpen
Belgium
Region
Vlaams Gewest Prov. Antwerpen Arr. Antwerpen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)